CAS RN: 870006-68-1
Methyl 8-methoxy-11-methyl-6,10-dioxo-1,4,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,8-triene-3-carboxylate
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20260516 |
10mg |
Out of stock |
15 business days | Inquiry |
GET A QUOTE
870006-68-1 / methyl 8-methoxy-11-methyl-6,10-dioxo-1,4,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,8-triene-3-carboxylate
Standard CAS: 870006-68-1
Multi CAS: No
Basic Information
CAS
870006-68-1
Multi CAS
No
Molecular Formula
C13H14N4O5
Molecular Weight
306.270000
Exact Mass
306.096420
InChI
InChI=1S/C13H14N4O5/c1-16-4-5-17-8-6(10(21-2)9(17)12(16)19)11(18)15-14-7(8)13(20)22-3/h4-5H2,1-3H3,(H,15,18)
InChIKey
SZRKRBXCNOEUIP-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
22
Aromatic heavy atom count
9
Fraction Csp3
0.38
Rotatable bonds
2
H-bond acceptors
7
H-bond donors
1
Molar refractivity
75.21
TPSA
106.52
LogP / Solubility
WLOGP
-0.39
MLOGP
-0.33
XLogP3
-0.5
Consensus LogP
-0.41
Log S (ESOL)
-1.66
Class (ESOL)
Soluble
Log S (Ali)
-1.79
Class (Ali)
Soluble
Log S (SILICOS-IT)
-1.56
Class (SILICOS-IT)
Soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-4.87
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
Yes
Synthetic Accessibility
2.5